The mission of the Best Practices Workgroup is to fulfill the requirement of section 21 of Chapter 244 of the Acts of 2012, An Act Relative to Prescription Drug Diversion, Abuse and Addiction to investigate and study best practices, including those in education, prevention, screening, tracking, monitoring and treatment, to promote safe and responsible opioid prescribing and dispensing practices for acute and chronic pain.  The goals of this study are to reduce diversion, abuse and addiction of opioid prescription medications as well as protect access for patients suffering from acute and chronic pain. The Workgroup will develop a report of recommendations and findings that will be submitted to the legislature.

Upcoming Meetings

Posted 4:45PM on February 14, 2014

Joint Policy Working Group

Thursday, February 20, 2014, 9:00a – 11:00a
Massachusetts Department of Public Health
250 Washington Street, Boston, Massachusetts 02108
PHC Conference Room, 2nd Floor

Draft Agenda

I. Review December 18, 2013 Meeting Minutes

II. Guest Speakers: Patient and Family Impact of Prescription Drug Abuse

A. Guest Speaker - Rebecca Reilly

B. Guest Speaker - Jack Reilly

III. Policy Working Group Discussion

a. Six legislative focus areas (Education, Prevention, Screening, Tracking, Monitoring and Treatment)

b. Future considerations

IV. Delegates Discussion

a. Protecting the patient

b. Protecting the provider

V. 2014 meetings

Prior Meetings

Meeting of Wednesday, December 18, 2013

Agenda

Documents

Actions

Approved November 8, 2013 Meeting Minutes

Meeting of Friday, November 8, 2013

Agenda

Documents

Actions

Approved October 9, 2013 Meeting Minutes

Meeting of Wednesday, October 9, 2013

Agenda

Documents

Actions

Approved September 9, 2013 Meeting Minutes

Meeting of Monday, September 9, 2013

Agenda

Documents

Actions

Approved July 26, 2013 Meeting Minutes

Meeting of Friday, July 26, 2013

Agenda

Documents

Actions

Approved April 25, 2013 Meeting Minutes

Meeting of Thursday, April 25, 2013

Agenda

Documents


This information is provided by the Drug Control Program within the Department of Public Health.